Strategies to Overcome the Most Common Misses in Clinical Practice Online Course


Expectations of higher clinical productivity further the potential for interpretive errors. Enhancing physicians' abilities to assess and distinguish between common misses is necessary to reduce errors and help them improve performance. This course will discuss how to implement practice-based strategies to turn errors into opportunities in both acute and routine imaging settings. This course provides a breadth of topics that span adult and pediatric spectrum and leverages the expertise of renowned radiology faculty from around the country. The course not only reviews clinical cases, but also incorporates skills and strategies to overcome misses utilizing advanced technology. In-Training Members will receive a discounted price of $375 after login  


Target Audience:
The target audience for this activity is radiologists at all training levels who read and interpret imaging in adult and pediatric radiology.

Goals and Objectives:
After completing the material in this activity, the learner should be able to: ol class="bd8pt">
  • Formulate a process for peer learning.
  • Discuss the potential and limitations of artificial intelligence for enhancing radiologist performance.
  • Identify how the appropriate use of standardized reporting systems such as LI-RADS® and TI-RADS™ can improve performance and reduce errors.
  • Recognize common misses and misdiagnoses in each discipline in radiology.
  • Describe strategies that assist in improving diagnosis in adult and pediatric radiology.


  • Disclosure of Commercial Interest:
    ARRS staff involved with this activity have nothing to disclose. Below is a listing of activity's contributors and planners disclosures:

    Planners
    • A. Paladin has nothing to disclose.
    • J. Leyendecker has nothing to disclose.
    • T. Kennedy has nothing to disclose.
    • G. Phillips has nothing to disclose.
    • K. Husk has nothing to disclose.
    • J. Long has nothing to disclose.

    Speakers, Authors, and Co-Authors

    Module 1 – Noninterpretive
    • J. Courtier has nothing to disclose.
    • D. Kim has nothing to disclose.
    • C. Young has nothing to disclose.
    • E. Dedekam has nothing to disclose.
    • M. Hartung has nothing to disclose.

    Module 2 – Neuroradiology
    • A. Kuner has nothing to disclose.
    • D. Wayer has nothing to disclose.
    • A. Grayev has nothing to disclose.
    • H. Rowley has nothing to disclose.
    • Weinberg has nothing to disclose.
    • Gore has nothing to disclose.
    • M. Hoch has nothing to disclose.
    • P. Chapman has nothing to disclose.
    • Singhal has nothing to disclose.
    • H. Sotoudeh has nothing to disclose.
    • L. Ledbetter receives book royalties from Elsevier.
    • K. Werth has nothing to disclose.

    Module 3 – Musculoskeletal Imaging
    • J. Stephenson has nothing to disclose.
    • J. Choi has nothing to disclose.
    • J. Baker has nothing to disclose.
    • T. Hillen receives consulting fees from Medtronic, SI-BONE, and Ultragenyx Pharmaceutical.
    • M. Ho is the recipient of a research grant from the Radiology Society of North, the Pilot Award from the Society of Pediatric Radiology, the Hanafee Research Grant from American Socity of Head and Neck Radiology. She receives an honorarium from BioMarin Pharmaceuticals.

    Module 4 – Levering Data and Technology
    • M. Richardson has nothing to disclose.
    • T. O'Neill has nothing to disclose.
    • F. Siddiqui has nothing to disclose.
    • E. Schneider has nothing to disclose.
    • J. Leyendecker has nothing to disclose.
    • R. Mody has nothing to disclose.

    Module 5 – Technique and Reporting
    • S. Eberhardt has nothing to disclose.
    • K. Gardner has nothing to disclose.
    • K. Fowler receives research support from GE Healthcare and Bayer. She also receives grant support from Pfizer. She receives a consulting fee from Medscape. Dr. Fowler has a Lab Service Agreement from 12 Sigma Technologies.
    • G. Cunha has nothing to disclose.
    • D. Fetzer receives speaker’s fees, consulting fees and research support from Philips Healthcare North American LLC. Dr. Fetzer receives speaker fees and research support from Siemens Medical Solutions, USA.
    • K. Vijay has nothing to disclose.
    • Y. Ng has nothing to disclose.
    • T. Browning is a consultant for Change Healthcare.
    • A. Kambadokone has nothing to disclose.
    • A. Parakh has nothing to disclose.
    • N. Pisuchpen has nothing to disclose.

    Module 6 – Body Imaging
    • D. Childs has nothing to disclose.
    • A. Morshid has nothing to disclose.
    • K. Blair has nothing to disclose.
    • K. Elsayes has nothing to disclose.
    • D. Morgan is a consultant GE Healthcare. Her institution receives research support from GE Healthcare.
    • S. Galgano has nothing to disclose.
    • K. Sharbidre has nothing to disclose.
    • B. Wildman-Tobriner has nothing to disclose.
    • P. Whitworth has nothing to disclose.
    • B. Allen has nothing to disclose

    Module 7 – IR, ER, and Nuclear Medicine
    • A. Gunn receives speaker and recipient of consulting fees from BTG. He also research support from Penumbra, Inc. and consulting fees from AngioDynamics, Inc. and Terumo Corporation.
    • M. Zapadka has nothing to disclose.
    • C. Lack has nothing to disclose.
    • J. Sachs has nothing to disclose.
    • P. Kuo receives consulting fees from Endocyte; consulting and speaker’s fees from General Electric Healthcare; speaker fees from Lilly; consulting fees from inviCRO; consulting fees from Progenics; and consulting fees from Imaging Endpoints, Bayer, Konica Minolta and Novartis. Dr. Kuo has research grants from Blue Earth and Progenics.
    • M. Kay has nothing to disclose.
    • C. LeBedis has nothing to disclose.
    • C. Hon has nothing to disclose.
    • P. Haran has nothing to disclose.
    • J. Wang has nothing to disclose.
    • M. Hartman has nothing to disclose.

    Module 8 – Women's Imaging
    • H. Greenwood has nothing to disclose.
    • L. Wang has nothing to disclose.
    • S. Friedewald has nothing to disclose.
    • S. Bhole has nothing to disclose.
    • S. Rao has nothing to disclose.
    • D. Gupta has nothing to disclose.
    • K. Shampain has nothing to disclose.
    • M. Dighe received a research grant from Phillips Medical Imaging.

    Module 9 – Pediatric Imaging
    • A. Chaturvedi has nothing to disclose.
    • A. Brahmbhatt has nothing to disclose.
    • L. Monterroso has nothing to disclose.
    • N. Klionsky has nothing to disclose.
    • G. Phillips has nothing to disclose.
    • J. Otjen has nothing to disclose.
    • A. Ngo has nothing to disclose.
    • M. Thapa has nothing to disclose.

    Module 10 – Chest and Cardiovascular Imaging
    • C. Chiles has nothing to disclose.
    • R. Munden has nothing to disclose.
    • S. Patel has nothing to disclose.
    • Vlahos has nothing to disclose.
    • J. Chung receives royalities from Elsevier/Amirsys. Dr. Chung receives consultant fees from Boehringer Ingelheim, Genentech, and Veracyte and speaker fees from Boehringer Ingelheim and Genentech.
    • J. Bueno has nothing to disclose.


    Member Price:
    $745.00
    NonMember Price:
    $995.00

    Accreditation Statement
    The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.

    Designation Statement
    The ARRS designates this educational activity for a maximum of 26.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.

    The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The ARRS designates this enduring activity for a maximum of 26.5 AMA PRA Category 1 Credit(s)™ and 26.5 American Board of Radiology©, MOC Part II, Self-Assessment CME (SA-CME.) Physicians should claim only the credit commensurate with the extent of their participation in the activity.



    Date of issuance: September 1, 2020
    Date of expiration: August 31, 2026
    Estimated time to complete the activity: 26.5 hour(s)